Approval · Notice of Compliance 22781 · 2019
FIRAZYR: Notice of Compliance 22781
Issued October 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22781
- Date
- October 11, 2019
- Company
- Shire Orphan Therapies Llc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug product manufacturing site and change in specifications
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIRAZYR | Not yet assigned | — |
Medicinal ingredients
- ICATIBANT ACETATE 10 MG per ML